You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkins and non-Hodgkins lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

Recruiting
  • Childhood Non-Hodgkin Lymphoma
  • +2 more
  • Goal Management Training (GMT)
  • Brain Health Workshop (BHW)
  • Oslo, Norway
  • +2 more
May 25, 2022

CD20 Positive Non Hodgkin Lymphoma Trial in United States (CPO107)

Recruiting
  • CD20 Positive Non Hodgkin Lymphoma
  • Los Angeles, California
  • +4 more
Aug 9, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

Recruiting
  • Lymphomatoid Granulomatosis
  • +3 more
  • Interferon
  • Rituxan and EPOCH
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

Not yet recruiting
  • B-cell Non-Hodgkins Lymphoma (B-NHL)
  • (no location specified)
Jan 5, 2023

Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma Trial in Japan (tafasitamab, lenalidomide, parsaclisib)

Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
Jan 24, 2022

Circulating Cell DNA in Pediatric Mature B Cell Non-Hodgkins

Not yet recruiting
  • Non-hodgkin Lymphoma
  • modified BFM-95 protocol
  • (no location specified)
Jul 9, 2021

Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

Recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • Evaluation of first line treatment in patients with stage I and II LBCL
  • Paraná, Entre Ríos, Argentina
  • +6 more
Dec 29, 2022

B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Non Hodgkin Lymphoma
  • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
  • Aurora, Colorado
    Children's Hospital Colorado
Nov 9, 2022

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

    Completed
    Has Results
    • Non-Hodgkins Lymphoma
    • Fort Myers, Florida
    • +1 more
    Feb 21, 2022

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

    Terminated
    • Non-Hodgkins Lymphoma
    • +6 more
    • Huntsville, Alabama
    • +1 more
    May 5, 2022

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Chronic Lymphocytic Leukemia
    • Phoenix, Arizona
    • +10 more
    Nov 11, 2022

    Non-Hodgkins Lymphoma Trial in Philadelphia, Houston (hLL2 (epratuzumab))

    Terminated
    • Non-Hodgkins Lymphoma
    • hLL2 (epratuzumab)
    • Philadelphia, Pennsylvania
    • +1 more
    Aug 12, 2021

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022

    Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

    Recruiting
    • Leukemia
    • +5 more
    • Bone Marrow Transplant (BMT)
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Feb 14, 2022

    Hodgkin Lymphoma, Adolescent Behavior, Chemo Effect Trial (Description of therapeutical results)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Description of therapeutical results
    • (no location specified)
    Dec 15, 2022

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

    Active, not recruiting
    Has Results
    • Acute Myelogenous Leukemia
    • +10 more
    • Atlanta, Georgia
    • +2 more
    Feb 9, 2022

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Beijing, Beijing, China
    • +9 more
    Jan 17, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Charlotte, North Carolina
    • +21 more
    Jan 18, 2023

    Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

    Active, not recruiting
    • Hodgkin Disease
    • Houston, Texas
      Texas Children's Hospital
    Jan 19, 2022

    Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • IM-TMI (3Gy)
    • +3 more
    • Chicago, Illinois
      University of Illinois at Chicago
    May 18, 2021